What is the preferred treatment between Penicillin (Penicillin V potassium) VK and Amoxicillin for Group B streptococcus (strep B)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Penicillin VK vs Amoxicillin for Group B Streptococcus

For Group B Streptococcus (GBS) infections, penicillin is the preferred agent over amoxicillin due to its narrower spectrum of activity, although both are equally effective. 1

Clinical Context Matters

The choice between penicillin VK and amoxicillin depends on the specific clinical scenario:

For Intrapartum Prophylaxis (Preventing Neonatal GBS)

  • Intravenous penicillin G is the first-line agent, not oral penicillin VK, with a regimen of 5 million units IV initially, then 2.5 million units IV every 4 hours until delivery 2, 1
  • Ampicillin (not amoxicillin) is the acceptable alternative for intrapartum prophylaxis: 2 g IV initially, then 1 g IV every 4 hours until delivery, though it is considered second-line due to broader spectrum 2, 1
  • The narrow spectrum of penicillin G makes it superior for prophylaxis because it minimizes disruption of maternal and neonatal flora 2, 1

For Active GBS Infections (Sepsis, Meningitis, Soft Tissue)

  • High-dose IV penicillin G (2-4 million units every 4-6 hours) is the drug of choice for serious invasive GBS disease 1, 3
  • Higher doses are required because GBS has somewhat higher minimum inhibitory concentrations compared to Group A Streptococcus 3
  • No documented penicillin resistance exists in GBS anywhere in the world 4, 5

For Oral Therapy (If Applicable)

  • Neither penicillin VK nor amoxicillin is typically used for GBS because most GBS infections requiring treatment are serious enough to warrant IV therapy 1, 3
  • If oral therapy were considered for minor infections, amoxicillin would have better bioavailability than penicillin VK, though this is not a standard recommendation for GBS 6

Important Distinctions from Group A Streptococcus

Do not confuse GBS treatment with strep throat (Group A Streptococcus), where penicillin VK and amoxicillin are both acceptable first-line oral agents 2, 6. For GBS:

  • The infections are typically more severe (neonatal sepsis, meningitis, bacteremia) 3
  • IV therapy is standard, not oral 1
  • The clinical context is usually perinatal or in immunocompromised/elderly adults 3, 7

Key Pitfalls to Avoid

  • Do not use amoxicillin-clavulanate (Augmentin) for GBS - the clavulanate adds no benefit since GBS does not produce beta-lactamase, and it unnecessarily broadens the spectrum 1
  • Do not rely on erythromycin or clindamycin without susceptibility testing - resistance rates have increased to 16-21% for erythromycin and 4-9% for clindamycin 8, 4
  • Do not use gentamicin monotherapy - while combination therapy with penicillin plus gentamicin accelerates bacterial killing, all GBS strains show high-level gentamicin resistance when used alone 4, 5

Penicillin-Allergic Patients

For patients with penicillin allergy:

  • Non-anaphylactic allergy: Use cefazolin 2 g IV initially, then 1 g IV every 8 hours 2
  • High-risk anaphylaxis: Use clindamycin or erythromycin only if susceptibility testing confirms sensitivity; otherwise use vancomycin 1 g IV every 12 hours 2, 1

References

Guideline

Group B Streptococcal Infections Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antibiotic-killing kinetics of group B streptococci.

The Journal of pediatrics, 1976

Guideline

Treatment of Strep Throat

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.